Conditions & Treatments

Inherited Blood Disorders

Assessment priorities, genetic counseling, transfusion management, and further treatment options for alpha-globin gene-related anemia.

Severity assessment, long-term management, hematopoietic stem cell transplantation, and preparation for care in China.

Evaluation of anemia, pain crises and organ complications, with guidance on comprehensive treatment and follow-up pathways.

Bleeding risk assessment for clotting factor deficiencies, replacement therapy, complication management, and cross-border care preparation.

Enzyme and genetic testing, organ involvement assessment, long-term treatment options, and multidisciplinary management priorities.

Hepatic and neurological assessment for copper metabolism disorders, plus standardized treatment, monitoring, and long-term management.

Disease re-evaluation, immunotherapy, cell therapy, and specialist consultation pathways for relapsed or refractory ALL.

Stratified assessment, novel agents, cell therapy, and individualized treatment planning for relapsed or refractory myeloma.

Re-classification, response assessment, immunotherapy, and cell therapy consultation for relapsed or refractory lymphoma.